Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANAB Anaptysbio Inc

已收盘 11-21 16:00:00 EST

21.17

+0.86

+4.23%

盘后21.17

+0.000.00%

16:20 EST

最高21.64	最低20.23	成交量36.47万
今开20.41	昨收20.31	日振幅6.94%
总市值6.44亿	流通市值4.21亿	总股本3,043万
成交额768.79万	换手率1.83%	流通股本1,988万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANAB","market":"US","secType":"STK","nameCN":"Anaptysbio Inc","latestPrice":21.17,"timestamp":1732222800000,"preClose":20.31,"halted":0,"volume":364685,"hourTrading":{"tag":"盘后","latestPrice":21.17,"preClose":21.17,"latestTime":"16:20 EST","volume":7624,"amount":161400.08,"timestamp":1732224000865},"delay":0,"floatShares":19881595,"shares":30428682,"eps":-6.043375,"marketStatus":"已收盘","marketStatusCode":5,"change":0.86,"latestTime":"11-21 16:00:00 EST","open":20.41,"high":21.64,"low":20.23,"amount":7687908.43886,"amplitude":0.069424,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.043375,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732266000000},"adr":0,"listingDate":1485406800000,"adjPreClose":20.31,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":20.45,"preClose":20.31,"latestTime":"09:29 EST","volume":106,"amount":2160.11994,"timestamp":1732199393046},"postHourTrading":{"tag":"盘后","latestPrice":21.17,"preClose":21.17,"latestTime":"16:20 EST","volume":7624,"amount":161400.08,"timestamp":1732224000865},"volumeRatio":0.780063,"impliedVol":2.6298,"impliedVolPercentile":0.9921},"requestUrl":"/m/hq/s/ANAB","defaultTab":"news","newsList":[{"id":"2485443591","title":"Anaptysbio, Inc.盘中异动 股价大涨5.17%报21.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485443591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485443591?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:49","pubTimestamp":1732211397,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日01时49分，Anaptysbio, Inc.股票出现波动，股价急速上涨5.17%。截至发稿，该股报21.36美元/股，成交量12.0891万股，换手率0.40%，振幅4.97%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Briacell Therapeutics Corp.、Conduit Pharmaceuticals Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为943.68%、523.52%、388.50%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为162.20%、81.04%、76.33%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122014957abd53a28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122014957abd53a28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB","RA"],"gpt_icon":0},{"id":"2484972943","title":"Anaptysbio, Inc.盘中异动 下午盘股价大涨5.14%报19.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484972943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484972943?lang=zh_cn&edition=full","pubTime":"2024-11-20 03:36","pubTimestamp":1732044978,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日03时36分，Anaptysbio, Inc.股票出现异动，股价快速上涨5.14%。截至发稿，该股报19.85美元/股，成交量21.7748万股，换手率0.72%，振幅6.09%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为1.43%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Syros Pharmaceuticals, Inc.、Tff Pharmaceuticals, Inc.、Exicure, Inc.较为活跃，换手率分别为1237.26%、841.47%、151.72%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Dogwood Therapeutics, Inc.，振幅分别为91.10%、81.67%、68.54%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120033618abcfee66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120033618abcfee66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB","RA"],"gpt_icon":0},{"id":"2484674587","title":"Anaptysbio, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484674587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484674587?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:07","pubTimestamp":1731942455,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时07分，Anaptysbio, Inc.股票出现波动，股价急速下跌5.11%。截至发稿，该股报18.03美元/股，成交量4.4611万股，换手率0.15%，振幅4.53%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为553.97%、483.26%、331.39%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为118.81%、75.18%、73.24%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111823073698e4346d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111823073698e4346d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB","RA"],"gpt_icon":0},{"id":"2483061813","title":"Anaptysbio, Inc.2024财年第三财季实现净利润-32.85百万美元，同比增加11.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483061813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483061813?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686434,"startTime":"0","endTime":"0","summary":"11月16日，Anaptysbio, Inc.公布财报，公告显示公司2024财年第三财季净利润为-32.85百万美元，同比增加11.95%；其中营业收入为30.02百万美元，同比增加804.22%，每股基本收益为-1.14美元。从资产负债表来看，Anaptysbio, Inc.总负债4.09亿美元，其中短期债务1.89百万美元，资产负债比为1.21，流动比率为0.11。机构评级：截至2024年11月16日，当前有11家机构对Anaptysbio, Inc.目标价做出预测，其中目标均价为54.36美元，其中最低目标价为30.00美元，最高目标价为90.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000303abc515e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000303abc515e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB"],"gpt_icon":0},{"id":"2483530975","title":"Anaptysbio, Inc.盘中异动 快速下跌5.11%报19.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483530975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483530975?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:53","pubTimestamp":1731685980,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时53分，Anaptysbio, Inc.股票出现异动，股价急速下跌5.11%。截至发稿，该股报19.14美元/股，成交量6.1232万股，换手率0.20%，振幅6.35%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为3.36%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115235301a23b84c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115235301a23b84c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2483545059","title":"Anaptysbio, Inc.盘中异动 下午盘股价大跌5.13%报21.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483545059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483545059?lang=zh_cn&edition=full","pubTime":"2024-11-13 04:19","pubTimestamp":1731442772,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日04时19分，Anaptysbio, Inc.股票出现波动，股价急速下跌5.13%。截至发稿，该股报21.25美元/股，成交量30.1503万股，换手率0.99%，振幅6.54%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为1.16%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111304193298e422b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111304193298e422b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","ANAB","BK4139"],"gpt_icon":0},{"id":"2482735889","title":"Anaptysbio, Inc.盘中异动 早盘急速拉升5.40%报22.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482735889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482735889?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:53","pubTimestamp":1731336838,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时53分，Anaptysbio, Inc.股票出现异动，股价大幅上涨5.40%。截至发稿，该股报22.46美元/股，成交量3.4123万股，换手率0.11%，振幅4.36%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc.涨幅较大，Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为448.91%、234.02%、104.73%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Revelation Biosciences, Inc.，振幅分别为76.29%、31.82%、28.01%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111225358971a5ba7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111225358971a5ba7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2481064986","title":"Anaptysbio, Inc.盘中异动 股价大涨9.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481064986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481064986?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:35","pubTimestamp":1730903707,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时35分，Anaptysbio, Inc.股票出现波动，股价快速上涨9.26%。截至发稿，该股报21.72美元/股，成交量2.3993万股，换手率0.08%，振幅6.39%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1070.77%、106.67%、55.19%，振幅较大的相关个股有Lakeshore Biopharma Co., Ltd、Inmed Pharmaceuticals Inc.、Immunitybio, Inc.，振幅分别为107.44%、106.04%、105.49%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622350795bddc39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622350795bddc39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RA","ANAB"],"gpt_icon":0},{"id":"1147787668","title":"异动解读 | 分析师看涨前景 AnaptysBio盘前大涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1147787668","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147787668?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:22","pubTimestamp":1730902954,"startTime":"0","endTime":"0","summary":"生物技术公司AnaptysBio今日盘前大涨5%,引发市场广泛关注。根据路透社最新报道,虽然分析师下调了AnaptysBio的目标价,但大部分分析师仍然看好这家公司未来前景,予以\"买入\"评级。具体来看,尽管分析师们普遍预计AnaptysBio即将公布的2024年第三季度财报将出现营收下降和亏损,但他们上调了对该公司的盈利预期,并给予较高的12个月目标股价中位数。这反映出分析师们对AnaptysBio长期增长潜力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 分析师看涨前景 AnaptysBio盘前大涨5%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ANAB"],"gpt_icon":0},{"id":"2481600312","title":"AnaptysBio Inc   预计每股亏损1.59美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481600312","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481600312?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:19","pubTimestamp":1730902799,"startTime":"0","endTime":"0","summary":"   * AnaptysBio公司   在公布截至2001年1月1日的业绩报告时，预计将出现季度收入下降。* 根据LSEG的数据，12位分析师的平均预期显示，这家总部位于加利福尼亚州圣迭戈的公司的营收将从去年同期的901万美元下降7.2%，至835.3万美元。* LSEG分析师对AnaptysBio公司的平均预期是每股亏损1.59美元。* 华尔街对 AnaptysBio Inc 的 12 个月目标价中位数为 48.50 美元，高于其最新收盘价 19.88 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"AnaptysBio Inc   预计每股亏损1.59美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANAB"],"gpt_icon":0},{"id":"2481624519","title":"美国研究综述-阿波罗、Booking Holdings、Portillos","url":"https://stock-news.laohu8.com/highlight/detail?id=2481624519","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481624519?lang=zh_cn&edition=full","pubTime":"2024-11-06 17:15","pubTimestamp":1730884501,"startTime":"0","endTime":"0","summary":"    路透11月6日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括阿波罗、Booking Holdings 和 Portillos。要闻 * 阿波罗  ：摩根大通将目标价从143美元上调至161美元 * Aris Water Solutions Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性  * Booking Holdings Inc   ：Truist Securities将目标价从4100美元上调至4700美元  * Choice Hotels International Inc   ：杰富瑞将其评级从 \"买入 \"下调至 \"持有  * Portillos Inc   ：Stifel将其评级从 \"买入 \"下调至 \"持有  以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","AHCO","EMR","CTRE","ABNB","AIG","ADUS","CC","ANAB","BK4113","LU0708994859.HKD","LU2065169927.USD","AVB","ACLX","LU0029874061.USD","LU0426417589.USD","MO","BR","ABBV","AMH","ALL","BKNG","GO","BEAM","HPK","BK4141","DBRG","IT","AGCO","EMN","BLDR","BRKR","EXAS","FRPT","GFS","GXO","CHH","GMED","APO","ARIS","FIS","AZPN","BVS","BOW","CE","CMI","INZY","APLS","LU0868494708.USD","LU0390134368.USD"],"gpt_icon":0},{"id":"2480589012","title":"Anaptysbio, Inc.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480589012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480589012?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:35","pubTimestamp":1730730939,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时35分，Anaptysbio, Inc.股票出现波动，股价急速跳水5.26%。截至发稿，该股报20.54美元/股，成交量1.3423万股，换手率0.04%，振幅4.11%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Neurogene Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为236.79%、140.96%、45.87%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为29.83%、22.67%、16.12%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223539971a4276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223539971a4276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","ANAB"],"gpt_icon":0},{"id":"2479080970","title":"Anaptysbio, Inc.盘中异动 早盘急速跳水5.14%报21.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479080970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479080970?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:34","pubTimestamp":1730381669,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时34分，Anaptysbio, Inc.股票出现异动，股价急速跳水5.14%。截至发稿，该股报21.04美元/股，成交量1.4213万股，换手率0.05%，振幅6.33%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为1.87%。其相关个股中，Aerovate Therapeutics, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Engene Holdings Inc C/Wts 31/10/2028  Cl A涨幅较大，Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为196.95%、190.01%、146.40%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Equillium, Inc.、Evogene Ltd.，振幅分别为21.98%、14.49%、14.16%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213429971a3870&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213429971a3870&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2479825667","title":"美股异动 | 礼来(LLY.US)终止PD-1激动剂候选药物研究 AnaptysBio(ANAB.US)暴跌超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479825667","media":"智通财经网","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479825667?lang=zh_cn&edition=full","pubTime":"2024-10-30 22:26","pubTimestamp":1730298360,"startTime":"0","endTime":"0","summary":"周三，AnaptysBio(ANAB.US)股价走低，截至发稿，该股跌超20%，报24.455美元。AnaptysBio正在推进一种与礼来(LLY.US)PD-1激动剂抗体Peresolimab类似的关节炎疗法，在礼来宣布决定终止对该候选药物的研究后，AnaptysBio股价大跌。今年7月，H.C. Wainwright首次覆盖AnaptysBio，给予“买入”评级和55美元的目标价。该行认为其旗下的PD-1激动剂rosnilimab可能比peresolimab更有效。rosnilimab的试验初步数据预计将在2025年第一季度公布。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-30/doc-incukean0821980.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"69b555e67b9b57f18da6272607047169","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-30/doc-incukean0821980.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00B2B36J28.USD","BK4585","LU0094547139.USD","IE00B1BXHZ80.USD","LU1064131342.USD","LU0354030511.USD","LU0198837287.USD","BK4516","IE00BJT1NW94.SGD","PD","LU0471298694.HKD","LU0882574139.USD","LU1057294990.SGD","IE00BK4W5L77.USD","LU0417517546.SGD","LLY","IE00BK4W5M84.HKD","LU0203202063.USD","LU0456855351.SGD","LU0256863902.USD","LU0823416689.USD","LU0061475181.USD","GB00BDT5M118.USD","IE00B4R5TH58.HKD","LU0006306889.USD","LU0943347566.SGD","ANAB","LU0354030438.USD","LU0114720955.EUR","IE0004445239.USD","LU0672654240.SGD","BK4588","LU1035775433.USD","LU1023059063.AUD","BK4581","LU0238689110.USD","IE0002141913.USD","LU0320765059.SGD","LU0096364046.USD","IE00BJLML261.HKD","BK4533","LU0640476718.USD","LU0820561818.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","BK4023","LU0079474960.USD","BK4534","BK4139","LU0106261372.USD"],"gpt_icon":0},{"id":"2479783196","title":"Anaptysbio, Inc.盘中异动 早盘急速下跌25.19%报23.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479783196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479783196?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:32","pubTimestamp":1730295147,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时32分，Anaptysbio, Inc.股票出现波动，股价大幅跳水25.19%。截至发稿，该股报23.04美元/股，成交量32.1528万股，换手率1.06%，振幅2.41%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1795.46%、99.39%、17.05%，振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Cormedix Inc.，振幅分别为27.09%、11.49%、11.41%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021322895bd8e26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"69b555e67b9b57f18da6272607047169","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021322895bd8e26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB","RA"],"gpt_icon":0},{"id":"2479200007","title":"BUZZ-礼来公司将 AnaptysBio 公司的关节炎药物从管线中撤出，导致 AnaptysBio 公司暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2479200007","media":"Reuters","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479200007?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:22","pubTimestamp":1730294573,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    10月30日 - ** 生物技术公司 AnaptysBio    股价盘前下跌约 29% 至 21.99 美元** 制药巨头礼来  在一份投资者简报中披露，该公司已将ANAB公司用于治疗类风湿性关节炎的PD-1激动剂peresolimab从其产品线中撤出。 ** Leerink Partners 的分析师在一份说明中写道：\"临床项目的终止对 ANAB 的 PD-1 激动剂罗利单抗的前景是不利的。 ** 截至上一交易日收盘，ANAB 的年累计涨幅约为 44","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"69b555e67b9b57f18da6272607047169","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BUZZ-礼来公司将 AnaptysBio 公司的关节炎药物从管线中撤出，导致 AnaptysBio 公司暴跌","news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640476718.USD","LU0096364046.USD","IE00B4R5TH58.HKD","BK4139","IE00B1BXHZ80.USD","LU0820561909.HKD","IE00BFTCPJ56.SGD","LU0320765059.SGD","LU0385154629.USD","LU0256863811.USD","LU0823416689.USD","IE00BJJMRZ35.SGD","LU0456855351.SGD","BK4533","LU1057294990.SGD","IE00BK4W5L77.USD","LU1093756168.USD","LU0203201768.USD","LU0256863902.USD","LU1023059063.AUD","LU0198837287.USD","LU0943347566.SGD","LU0094547139.USD","LU1069344957.HKD","BK4516","ANAB","LU0114720955.EUR","LU0058720904.USD","LU0354030438.USD","IE00BK4W5M84.HKD","LU0097036916.USD","LU0203202063.USD","LU0689472784.USD","LU0417517546.SGD","BK4581","LU0820561818.USD","BK4534","LU0882574055.USD","IE0009355771.USD","LU0006306889.USD","IE0004445239.USD","LU0466842654.USD","BK4585","LU0122379950.USD","LU0882574139.USD","IE0002141913.USD","LU0672654240.SGD","BK4007","LU0708995401.HKD"],"gpt_icon":0},{"id":"2478486145","title":"Anaptysbio, Inc.盘中异动 股价大跌5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478486145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478486145?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:35","pubTimestamp":1730122525,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时35分，Anaptysbio, Inc.股票出现异动，股价快速跳水5.84%。截至发稿，该股报30.16美元/股，成交量8.8553万股，换手率0.29%，振幅6.68%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.、Revance Therapeutics, Inc.涨幅较大，Tc Biopharm  Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为546.87%、48.35%、36.95%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Calidi Biotherapeutics, Inc.、Monopar Therapeutics Inc.，振幅分别为34.60%、18.35%、16.85%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821352598e3ecfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821352598e3ecfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","ANAB"],"gpt_icon":0},{"id":"2478670846","title":"Anaptysbio, Inc.盘中异动 大幅下跌5.27%报32.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478670846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478670846?lang=zh_cn&edition=full","pubTime":"2024-10-25 03:26","pubTimestamp":1729797969,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日03时26分，Anaptysbio, Inc.股票出现异动，股价快速下跌5.27%。截至发稿，该股报32.92美元/股，成交量52.3238万股，换手率1.73%，振幅6.39%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Quince Therapeutics, Inc.、Aligos Therapeutics, Inc.、Vaccinex, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃，换手率分别为293.09%、208.08%、198.36%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Qualigen Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为78.77%、71.78%、60.32%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025032610ab713dc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025032610ab713dc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","ANAB"],"gpt_icon":0},{"id":"2477383856","title":"美国研究综述-中心空间、吉利德、Gitlab","url":"https://stock-news.laohu8.com/highlight/detail?id=2477383856","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477383856?lang=zh_cn&edition=full","pubTime":"2024-10-21 19:25","pubTimestamp":1729509951,"startTime":"0","endTime":"0","summary":"    路透10月21日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 Centerspace、Gilead 和 Gitlab。* 吉利德  ：Leerink Partners将其评级从 \"跑赢大盘 \"上调至 \"跑赢大盘\"。* Gitlab Inc   ：Needham将其评级从 \"持有 \"上调至 \"买入 * Liberty Energy Inc   ：花旗集团将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLY","EAT","LNG","BLMN","CTRA","PINE","CMA","BKV","DVN","LU0061474960.USD","ARRY","IE00BJTD4N35.SGD","CAKE","CAPR","ARCB","GTLB","ELV","ANAB","OZK","CVS","RCUS","AES","FANG","ACLX","BSX","LU2362541513.USD","AN","DDOG","UPST","AR","BWA","PLAY","CPAY","LU1057294990.SGD","BANF","APA","DD","DTE","CSR","BTAI","LU2449327464.USD","CHRD","AMZN","CCK","BK4532","NFLX","AXP","IE00BWXC8680.SGD","LU1267930227.SGD","LU1989764664.SGD","CIVI"],"gpt_icon":1},{"id":"2475322948","title":"Anaptysbio, Inc.盘中异动 快速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475322948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475322948?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:46","pubTimestamp":1729093571,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时46分，Anaptysbio, Inc.股票出现异动，股价快速拉升5.17%。截至发稿，该股报34.99美元/股，成交量3.1678万股，换手率0.10%，振幅4.36%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，180 Life Sciences Corp.、Korro Bio, Inc.、Quoin Pharmaceuticals Ltd涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为6228.55%、1092.78%、793.20%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.，振幅分别为633.55%、279.52%、126.58%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016234611ab6a9323&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016234611ab6a9323&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB","RA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anaptysbio.com","stockEarnings":[{"period":"1week","weight":-0.0212},{"period":"1month","weight":-0.4258},{"period":"3month","weight":-0.4553},{"period":"6month","weight":-0.1506},{"period":"1year","weight":0.4333},{"period":"ytd","weight":-0.0518}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AnaptysBio, Inc.在特拉华成立于2005年11月。该公司是一家为了满足治疗消除炎症和免疫肿瘤的需求，而开发先入级抗体产品。他们开发使用自己的专利-抗体筛选技术平台，其平台目的是复制在体外的候选产品，以抗体产生的自然过程。他们的收入来源是合作研究和开发安排。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.00144},{"month":2,"riseRate":0.875,"avgChangeRate":0.0982},{"month":3,"riseRate":0.25,"avgChangeRate":-0.083331},{"month":4,"riseRate":0.375,"avgChangeRate":0.003799},{"month":5,"riseRate":0.375,"avgChangeRate":-0.031718},{"month":6,"riseRate":0.625,"avgChangeRate":0.007623},{"month":7,"riseRate":0.5,"avgChangeRate":0.019018},{"month":8,"riseRate":0.625,"avgChangeRate":0.039779},{"month":9,"riseRate":0.5,"avgChangeRate":0.004586},{"month":10,"riseRate":0.625,"avgChangeRate":0.20142},{"month":11,"riseRate":0.125,"avgChangeRate":-0.093623},{"month":12,"riseRate":0.714286,"avgChangeRate":0.114651}],"exchange":"NASDAQ","name":"Anaptysbio Inc","nameEN":"Anaptysbio Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anaptysbio Inc(ANAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anaptysbio Inc,ANAB,Anaptysbio Inc股票,Anaptysbio Inc股票老虎,Anaptysbio Inc股票老虎国际,Anaptysbio Inc行情,Anaptysbio Inc股票行情,Anaptysbio Inc股价,Anaptysbio Inc股市,Anaptysbio Inc股票价格,Anaptysbio Inc股票交易,Anaptysbio Inc股票购买,Anaptysbio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anaptysbio Inc(ANAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}